| Literature DB >> 27942146 |
Kohei Maruya1, Yasuyoshi Asakawa2, Hideaki Ishibashi3, Hiroaki Fujita4, Tomoyuki Arai4, Haruyasu Yamaguchi5.
Abstract
[Purpose] To evaluate the effect of a home exercise program on physical function in community dwelling elderly with pre-sarcopenia or sarcopenia.Entities:
Keywords: Home-based exercise; Pre-sarcopenia; Sarcopenia
Year: 2016 PMID: 27942146 PMCID: PMC5140826 DOI: 10.1589/jpts.28.3183
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1. Algorithm for the identification, selection and randomization of participants to the intervention and control groups. The flowchart includes participants who dropped out between the baseline and 6-month follow-up assessment. SMI: skeletal muscle index
Participants characteristics at baseline
| Intervention group (n=34) | Control group (n=18) | |
|---|---|---|
| Age (yrs) | 69.2 ± 5.6 | 68.5 ± 6.2 |
| Women (n) (%) | 19 (55.9) | 10 (55.6) |
| SP (n) (%) | 5 (14.7) | 1 (5.6) |
| BMI (kg/m2) | 20.3 ± 1.7 | 19.7 ± 2.0 |
| SMI (kg/m2) | 5.88 ± 0.67 | 5.96 ± 0.62 |
| %BF (%) | 24.4 ± 6.1 | 21.9 ± 5.7 |
| HGS (kg) | 24.9 ± 7.1 | 27.9 ± 6.8 |
| SLS (s) | 51.6 ± 42.7 | 71.5 ± 43.1 |
| WS (comfortable) (m/s) | 1.44 ± 0.26 | 1.47 ± 0.25 |
| WS (maximum) (m/s) | 1.91 ± 0.28 | 1.98 ± 0.21 |
| KES (Nm/kg) | 1.39 ± 0.42 | 1.45 ± 0.46 |
| GLFS-25 | 3.5 ± 3.5 | 3.2 ± 2.5 |
| EQ-5D | 0.906 ± 0.124 | 0.898 ± 0.118 |
| Frequency of walking (n) (%) | Non: 22 (64.7) ≥2 d/w: 12 (35.3) | Non: 8 (44.4) ≥2 d/w: 10 (55.6) |
| Frequency of other than walking (n) (%) | Non: 20 (58.8) ≥2 d/w: 14 (41.2) | Non: 12 (66.7) ≥2 d/w: 6 (33.3) |
Data are presented mean and standard deviation. Student’s t-test for continuous variables and χ2 test for categorical variables. yrs: years; SP: Sarcopenia; BMI: body mass index; SMI: skeletal muscle index; %BF: body fat percentage; HGS: hand grip strength; SLS: duration of single leg standing; WS: walking speed; KES: knee extension strength; GLFS-25: the 25-question Geriatric Locomotive Functional Scale; EQ-5D: Euro QOL; d/w: day per week
Change in measured variables, from baseline to the 6-month assessment
| Main effect | Interaction effect | |||||
|---|---|---|---|---|---|---|
| Intervention group (n=26) | Control group (n=14) | Between effect | Interaction effect | Effect size (η2) | ||
| BMI | Baseline | 20.2 ± 1.8 | 19.9 ± 2.1 | 0.029 | ||
| kg/m2 | 6 months | 20.2 ± 2.1 | 19.6 ± 2.5 | |||
| Time effect | * | |||||
| SMI | Baseline | 5.91 ± 0.66 | 6.02 ± 0.57 | 0.023 | ||
| kg/m2 | 6 months | 5.93 ± 0.65 | 5.95 ± 0.75 | |||
| Time effect | ||||||
| %BF | Baseline | 24.1 ± 6.3 | 21.9 ± 6.0 | 0.004 | ||
| % | 6 months | 23.3 ± 7.1 | 20.7 ± 6.5 | |||
| Time effect | ||||||
| HGS | Baseline | 24.8 ± 7.4 | 28.6 ± 6.5 | <0.001 | ||
| kg | 6 months | 26.1 ± 8.0 | 29.7 ± 7.8 | |||
| Time effect | ** | |||||
| SLS | Baseline | 60.5 ± 44.7 | 77.2 ± 41.5 | * | 0.132* | |
| s | 6 months | 77.2 ± 45.5 | 61.6 ± 40.4 | |||
| Time effect | * | |||||
| WS (comfortable) | Baseline | 1.48 ± 0.27 | 1.48 ± 0.26 | 0.012 | ||
| m/sec | 6 months | 1.46 ± 0.20 | 1.42 ± 0.17 | |||
| Time effect | ||||||
| WS (maximum) | Baseline | 1.95 ± 0.30 | 2.02 ± 0.17 | ** | 0.189** | |
| m/sec | 6 months | 1.97 ± 0.24 | 1.86 ± 0.16 | |||
| Time effect | ** | |||||
| KES | Baseline | 1.38 ± 0.42 | 1.55 ± 0.35 | * | 0.128* | |
| Nm/kg | 6 months | 1.69 ± 0.46 | 1.49 ± 0.80 | |||
| Time effect | ** | |||||
| GLFS-25 | Base line | 2.7 ± 2.7 | 2.9 ± 1.6 | ** | 0.139** | |
| 6 months | 2.5 ± 3.0 | 5.1 ± 4.1 | * | |||
| Time effect | * | |||||
| EQ-5D | Baseline | 0.909 ± 0.128 | 0.918 ± 0.114 | 0.021 | ||
| 6 months | 0.945 ± 0.100 | 0.917 ± 0.117 | ||||
| Time effect | ||||||
Data are presented mean and standard deviation. *p<0.05; **p<0.01. Post-hoc analysis of paired and independent t-tests. ANOVA, repeated-measure two-way analysis of variance. BMI: body mass index; SMI: skeletal muscle index; %BF: body fat percentage; HGS: handgrip strength; SLS: duration of single leg standing; WS: walking speed; KE: knee extension strength; GLFS-25: the 25-question Geriatric Locomotive Functional Scale; EQ-5D, Euro QOL
Change in sarcopenia and pre-sarcopenia status
| Normal | Pre-sarcopenia | Sarcopenia | ||||
|---|---|---|---|---|---|---|
| Baseline* | 6-month§ | Baseline* | 6-month§ | Baseline* | 6-month§ | |
| Intervention group (n=26) | 0 | 4 (15.4) | 21 (80.8) | 20 (76.9) | 5 (19.2) | 2 (7.7) |
| Control group (n=14) | 0 | 2 (14.3) | 13 (92.9) | 11 (78.6) | 1 (7.1) | 1 (7.1) |
*p=0.399, §p=0.993. Fisher’s exact test. Data are presented number (%).